12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks showed significant movement. Notably, Qilian Intl Hldg Gr, Sunshine Biopharma, and Galera Therapeutics were among the top gainers, with Qilian Intl leading with a 63.8% increase. On the downside, Vivos Therapeutics, ENDRA Life Sciences, and Applied Therapeutics experienced notable declines, with Vivos Therapeutics dropping 22.4%. The movements were largely attributed to the release of Q4 earnings reports for some companies.
March 29, 2024 | 8:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Galera Therapeutics shares increased by 28.57% to $0.18, following their Q4 earnings report.
The rise in GRTX shares is directly linked to the Q4 earnings report, indicating a positive market response to the company's financial performance.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 95
POSITIVE IMPACT
Qilian Intl Hldg Gr shares surged 63.8% to $1.04, with a market value of $37.1 million.
The significant rise in QLI's stock price, especially in after-market hours, indicates strong investor interest possibly due to positive market sentiment or recent company developments.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Sunshine Biopharma's stock rose 39.5% to $0.08, with a market cap of $8.3 million.
SBFM's notable increase suggests positive investor reaction, potentially due to favorable company news or market conditions.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Vivos Therapeutics shares fell 22.4% to $3.75, following their Q4 earnings report.
The decline in VVOS shares is attributed to the Q4 earnings report, suggesting the market reacted negatively to the company's financial results.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 95